Omega-3, built for
the way the body uses it.
EPA + DHA are only the beginning. The body doesn't use Omega-3 through one pathway. Digestion, absorption, transport, phospholipid synthesis, membrane incorporation and cellular metabolism all contribute to what ultimately happens to those fatty acids. We designed the Omega-3 Multiplier System around that journey.
Final serving size, capsule count and claims subject to released product specification and regulatory review.
Product photography · tap a thumbnail to enlarge
Dose is the easy question.
This is the one that matters.
Eighty-two seconds on what the body still has to do with EPA and DHA after they arrive — and why that unfinished work is the reason the system ships as two bottles.
Filmed for LipoCentric Nutra · 1:22 · sound on
The body doesn't use Omega-3
through one pathway.
That is the starting point for the Omega-3 Multiplier System. We looked beyond the capsule and considered the biological journey an EPA or DHA molecule has to complete.
Release
The lipid has to be released and processed in the gastrointestinal environment.
Availability
Digestion, bile-mediated solubilization, meal composition and molecular form influence how EPA and DHA become available.
Delivery
Available fatty acids enter intestinal lipid-transport pathways and circulate through the body.
Membrane building
EPA and DHA can enter tissue lipid pools and become incorporated into membrane phospholipids.
Biology
Membrane composition and lipid metabolism influence cellular signaling and physiological function.
Optimize the dose.
Increase EPA. Increase DHA. Increase concentration. The product story ends largely at delivery.
Understand the journey.
What happens to the molecule after it is swallowed — and what biological systems participate in using it?
Build around the journey.
Provide the lipid substrate in Bottle 01, then add a defined nutritional layer in Bottle 02 around selected phospholipid, nucleotide and cellular metabolic pathways that surround Omega-3 utilization.
Why we built a system instead of another high-dose Omega-3.
The formulation started with three requirements: an exceptional lipid foundation, a defined biological-support layer, and an architecture that protects both.
A high-integrity Omega-3 foundation.
We wanted a concentrated EPA + DHA source with a defined triglyceride form, strong purification standards and oxidative quality that could be evaluated batch by batch.
A biological assembly layer.
Once EPA and DHA are available, the body uses them within lipid pools, membranes and signaling pathways. Bottle 02 was designed around selected nutrients connected to Omega-3-linked phospholipid synthesis and cellular metabolism.
A formulation architecture that protects both.
Marine oil and powder-based nutrients have different stability, moisture and processing requirements. Separating them lets each side be optimized rather than compromised.
Two bottles. Two jobs.
One biological purpose.
Bottle 01 addresses the lipid foundation. Bottle 02 addresses selected Omega-3-supporting biological inputs that sit downstream of that foundation. Keeping them separate lets us formulate the oil for lipid stability and the powder system for its own payload and compatibility requirements.
Structural Omega System
- Norwegian VivoMega® Platinum 5525 TG
- 1,700 mg total Omega-3
- 1,100 mg EPA + 500 mg DHA
- Netextine® astaxanthin + mixed tocopherols
The foundation: deliver the marine fatty-acid substrates in a high-integrity lipid system.
Neuro-Cellular Activation System
- Citicoline (CDP-Choline)
- Uridine Monophosphate
- P5P
- L-Methylfolate
- Methylcobalamin
The support layer: selected Omega-3-supporting nutritional inputs connected to phospholipid synthesis, nucleotide metabolism and one-carbon cellular chemistry.
Every number on Bottle 01
has a reason to be there.
The foundation is deliberately built around the EPA and DHA content that reaches the consumer — with molecular form, oxidative integrity and antioxidant protection treated as part of the lipid system.
Norwegian VivoMega® Platinum 5525 TG
The specified marine source for Bottle 01. The triglyceride form is part of the formulation specification, alongside sourcing, purification and quality-control considerations.
The signalling side of the formula
EPA is incorporated into membrane lipid pools and serves as a precursor for distinct bioactive lipid mediators. It contributes the signaling-oriented side of the formula.
The structural side of the formula
DHA is particularly enriched in neural and retinal tissues and contributes to the physical and functional properties of membrane phospholipids.
Don't ask only how much Omega-3 is in the capsule. Ask what condition it arrives in.
EPA and DHA contain multiple double bonds and are susceptible to oxidation. That makes oxidative quality a meaningful part of the finished oil — not a technical footnote.
Cited batch · GOED maximum ≤ 5 meq/kg
Cited batch · GOED maximum ≤ 20
Cited batch · GOED maximum ≤ 26
| Oxidation parameter | GOED maximum | Cited VivoMega® batch |
|---|---|---|
| Peroxide Value | ≤ 5 meq/kg | 0.1 |
| p-Anisidine Value | ≤ 20 | 3 |
| TOTOX | ≤ 26 | 3 |
From availability, to utilization,
to membrane biology.
For Omega-3, availability is only the first layer. EPA and DHA then enter lipid transport and tissue metabolism, participate in phospholipid pools, and can become incorporated into cell membranes. Bottle 02 is designed around these Omega-3-linked processes.
Availability
EPA and DHA must first become available through digestion and intestinal lipid handling.
- Meal composition matters.
- Digestive processing matters.
- Molecular form matters.
- Individual physiology matters.
Utilization
Once available, Omega-3 enters circulating and tissue lipid pools and participates in lipid metabolism.
- Transport and tissue uptake.
- Lipid-pool handling.
- Phospholipid metabolism.
- Cellular metabolic environment.
Membrane biology
EPA and DHA can become components of membrane phospholipids — where structure and signaling intersect.
- Phospholipid synthesis.
- Membrane remodeling.
- Cellular communication.
- Downstream lipid signaling.
Bottle 02: the biological machinery built specifically around Omega-3.
Bottle 02 was formulated specifically around what the body does with the EPA and DHA delivered by Bottle 01. EPA and DHA are the structural Omega-3 substrates. Bottle 02 supplies Citicoline, Uridine, P5P, L-Methylfolate and Methylcobalamin as complementary inputs around the pathways involved in phospholipid synthesis, membrane assembly and cellular metabolism. In other words, Bottle 02 is not a separate wellness blend — it is the biological support layer of the Omega-3 system.
Citicoline
Provides the choline component used in phosphatidylcholine synthesis, placing it directly alongside the EPA + DHA structural fatty acids in the Omega-3 membrane-building architecture.
Uridine Monophosphate
Provides the nucleotide component associated with membrane synthesis, selected to work alongside the EPA + DHA substrate within the Omega-3 utilization architecture.
P5P
Provides active B-vitamin support for enzyme-dependent and one-carbon metabolism surrounding the phospholipid and membrane processes through which Omega-3 is utilized.
L-Methylfolate
Provides active B-vitamin support for enzyme-dependent and one-carbon metabolism surrounding the phospholipid and membrane processes through which Omega-3 is utilized.
Methylcobalamin
Provides active B-vitamin support for enzyme-dependent and one-carbon metabolism surrounding the phospholipid and membrane processes through which Omega-3 is utilized.
Why these five?
Because they answer the specific biological question Bottle 02 was designed to address. We deliberately did not turn it into a long list of popular nootropics that lack a defined connection to this architecture.
Four inputs. One biological build.
EPA and DHA provide the structural fatty acids. But building those fatty acids into phospholipid membranes requires more than the fatty acids themselves. The Kennedy Pathway provides a useful framework for understanding this: a choline donor, a nucleotide substrate and methylation-support nutrients work alongside structural fatty acids to support phospholipid synthesis. This is the biological logic that directly informed Bottle 02.
The delivery question
- How much EPA and DHA can we deliver?
- How concentrated is the oil?
- What molecular form is it?
- How is oxidation controlled?
The biological architecture question
- What is the quality of the EPA + DHA foundation?
- What roles do EPA and DHA play?
- What nutritional inputs are connected to phospholipid synthesis?
- How should oil and powder systems be formulated separately?
“How much Omega-3 can we put into one capsule?”
That question can produce an impressive label — but concentration alone doesn't explain the whole biological story.
- Total oil can obscure actual EPA + DHA content.
- Oxidative quality can be overlooked.
- EPA and DHA can be treated as interchangeable numbers.
- Additional ingredients can become an unrelated shopping list.
“What does the body do with Omega-3 — and how can we formulate around that biology?”
That question creates a more deliberate architecture.
- High-integrity EPA + DHA foundation.
- Oxidative integrity treated as core quality.
- Distinct EPA and DHA roles respected.
- Selected phospholipid, nucleotide and B-vitamin support around the biological assembly layer.
Every component had to answer the same four questions.
This is the simplest way to understand why the formula looks the way it does.
What biological role does it play?
If an ingredient cannot be assigned a defined role, it does not belong simply because it is popular.
Can we formulate it meaningfully?
A sophisticated ingredient name does not create a sophisticated formula if the dose or delivery format is compromised.
Does physical form matter?
Oil and powder systems have different stability and processing requirements. The architecture reflects that.
What evidence supports it?
Human, mechanistic and preclinical evidence answer different questions and should never be presented as interchangeable.
Complete the biological architecture — not just the capsule.
The Multiplier System is built around one connected idea: EPA and DHA are the Omega-3 substrate, while Bottle 02 supplies selected inputs that work alongside that substrate as the body processes, incorporates and utilizes Omega-3.
Don't compare Omega-3 by the front-of-pack number alone.
A serious comparison looks at actual EPA + DHA, oxidative integrity, molecular form, ratio, formulation architecture and evidence boundaries.
| Question | Typical Omega-3 approach | Omega-3 Multiplier System |
|---|---|---|
| What is delivered? | Often marketed by total fish-oil or Omega-3 number | 1,700 mg total Omega-3 with 1,100 mg EPA + 500 mg DHA specified |
| EPA:DHA philosophy | Varies widely | Approximately 2:1, chosen to provide substantial amounts of both |
| Molecular form | Varies by product | Norwegian VivoMega® triglyceride source specified |
| Oxidative quality | Often not prominent in consumer communication | PV, p-anisidine and TOTOX treated as core quality parameters |
| Second biological layer | Usually absent or broad | Citicoline + uridine + active B-vitamin architecture |
| Physical architecture | Typically one bottle | Two bottles designed for different formulation environments |
For people who want more thought behind their daily Omega-3.
The system is positioned as advanced nutritional support — not as a treatment for a disease or a substitute for individualized medical care.
Cognitive-demanded adults
For people whose daily lives involve sustained mental work and who want a deliberate DHA-containing lipid foundation rather than a generic fish-oil product.
Long-term cardiovascular nutrition
For adults looking to make EPA + DHA part of a broader daily nutritional strategy supporting normal cardiovascular physiology.
Active & performance-focused adults
For people who want high-quality Omega-3 as part of a broader recovery, cellular and metabolic nutrition routine.
Science-conscious consumers
For customers who want to see the source, EPA/DHA amounts, oxidative specifications and formulation rationale — not just a “triple strength” claim.
The formulation is only as good as the Omega-3 that actually reaches the bottle.
Source specification, oxidation testing and batch-level documentation are treated as part of the product architecture.
VivoMega® Platinum 5525 TG
Specified Norwegian triglyceride Omega-3 source used as the structural foundation of Bottle 01.
Oxidative integrity
Peroxide value, p-anisidine value and TOTOX are reviewed as core Omega-3 quality parameters.
Purity testing
Formulation documentation includes testing considerations for heavy metals, PCBs, dioxins/furans, PAHs and microbiological safety.
Batch traceability
QR-linked analytical documentation can connect the finished product to its batch verification record where provided.
The cited TOTOX and oxidation values on this page refer to the batch values used in the formulation documentation. Current released-batch specifications should always be verified against the applicable certificate of analysis.
Simple enough for daily use.
Precise enough to be a system.
Take Bottle 01 and Bottle 02 together as your daily Omega-3 Multiplier System protocol, preferably with a meal unless your healthcare professional advises otherwise.
Use individual medical guidance when it matters.
People taking medicines that may interact with Omega-3 supplementation, particularly anticoagulant therapy, those preparing for surgery, pregnant or breastfeeding individuals, or anyone managing a medical condition should discuss use with a qualified healthcare professional.
One product. Multiple biological architectures.
The Omega-3 Multiplier System can serve as the lipid foundation inside selected LipoCentric Nutra protocols. The goal is complementary biology — not indiscriminate stacking.
Omega-3 + Magnesium Evolution
Omega-3 provides the lipid/membrane layer while Magnesium Evolution provides a separate magnesium-dependent enzymatic and neurophysiological architecture.
Omega-3 + Berberine Evolution
Combines Omega-3 lipid nutrition with a distinct metabolic-regulation architecture rather than duplicating the same biological job.
Omega-3 + Magnesium + Berberine
Three complementary layers: membrane lipid biology, magnesium-dependent cellular processes and metabolic regulation.
Omega-3 + Targeted Collagen Peptides
Pairs lipid and membrane nutrition with a dedicated collagen/skin structural formulation.
Omega-3 + Essential Amino Acids
Pairs the lipid layer with an amino-acid substrate layer relevant to muscle protein synthesis and active-aging nutrition.
Omega-3 + Probiotic Evolution + Berberine Evolution
Combines a microbiome layer, metabolic layer and lipid/systemic nutrition layer — each with a different role.
What makes the Omega-3 Multiplier System different?
The science is part of the product experience. Here are the questions a serious customer should ask before buying.
Why does meal fat matter for Omega-3?
Evidence context: Lawson & Hughes, Biochem Biophys Res Commun. 1988; Davidson et al., Clin Ther. 2012; Offman et al., Clin Ther. 2019.
Is this just another fish-oil supplement?
No. Bottle 01 is the Omega-3 foundation, but the product is intentionally built as a two-part system. Bottle 02 adds a separate nutritional layer around phospholipid synthesis, nucleotide metabolism and active B-vitamin pathways.
Why are there two bottles?
Marine oil and powder-based nutrients have different stability, moisture and processing requirements. Separating them allows the Omega-3 lipid system and the Bottle 02 nutrient system to be formulated around their own physical and biological roles.
Why 1,100 mg EPA and 500 mg DHA?
EPA and DHA are not interchangeable molecules. The approximately 2:1 profile is our formulation choice to provide substantial amounts of both — rather than maximizing one at the expense of the other. It is not a claim that 2:1 is universally superior to every other ratio.
Why use triglyceride-form Omega-3?
The specified Bottle 01 source is a Norwegian VivoMega® triglyceride concentrate. TG is a natural marine lipid form and is part of our source specification. Molecular form matters, but it should be considered alongside EPA/DHA dose, meal context, oxidative quality and the overall formulation.
Why does TOTOX matter?
Omega-3 fatty acids are susceptible to oxidation. TOTOX combines peroxide and p-anisidine measurements to provide a broader picture of oxidative status. Our cited batch has a TOTOX value of 3 against the GOED maximum of 26; current batch documentation should always be checked against the released certificate of analysis.
What exactly does Bottle 02 do?
It supplies Citicoline, Uridine Monophosphate, P5P, L-Methylfolate and Methylcobalamin. These were selected because they map to phospholipid metabolism, nucleotide metabolism and broader cellular metabolic pathways that surround Omega-3 utilization. Bottle 02 is not intended to be a generic nootropic blend.
Does Bottle 02 increase Omega-3 absorption?
The food effect on Omega-3 absorption is well documented, and different delivery forms can behave differently under low-fat conditions. Bottle 02 is designed primarily around the post-absorption biology of utilization and membrane phospholipid synthesis. We therefore describe it as a utilization/biological-support layer, rather than simply adding more Omega-3 to the label.
Can I take it with Magnesium Evolution?
Yes, the products occupy complementary nutritional spaces and can be used together according to their respective labels. If you take medicines or have a medical condition, use individualized professional guidance.
Who should speak with a healthcare professional before use?
Anyone taking medicines that may interact with Omega-3 supplementation, particularly anticoagulant therapy, anyone preparing for surgery, pregnant or breastfeeding individuals, or anyone managing a medical condition should seek individualized advice before use.
Don't make the meal do all the work.
The formulation philosophy is simple: respect the food effect, optimize the lipid foundation, and then support the biology that follows.
The way people eat has changed.
The biology hasn't.
Meal composition is one part of Omega-3 bioavailability, and human studies show that dietary fat can influence absorption. But that is only one layer of the biological journey. The modern diet simply makes the broader formulation question more visible.
Smaller meals. Different macronutrient patterns.
Many adults deliberately reduce dietary fat or total calorie intake, while others follow structured weight-management approaches.
What happens beyond the meal?
Rather than treating the meal as the whole solution, we considered the complete biological journey of the Omega-3 molecule.
Build around human physiology.
Keep the lipid foundation strong, then support selected downstream pathways involved in Omega-3-linked phospholipid synthesis and cellular metabolism.